Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 398-405 , September 2009

Association of C-reactive protein with mild cognitive impairment

  • Rosebud O. Roberts

      Affiliations

    • Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author. Tel.: 507-284-5656; Fax: 507-284-1516.
    • ,
  • Yonas E. Geda

      Affiliations

    • Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Department of Psychiatry and Psychology, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • David S. Knopman

      Affiliations

    • Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Bradley F. Boeve

      Affiliations

    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Teresa J.H. Christianson

      Affiliations

    • Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • V. Shane Pankratz

      Affiliations

    • Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Iftikhar J. Kullo

      Affiliations

    • Division of Cardiovascular Diseases, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Eric G. Tangalos

      Affiliations

    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Division of Primary Care Internal Medicine, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Robert J. Ivnik

      Affiliations

    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Department of Psychiatry and Psychology, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Ronald C. Petersen

      Affiliations

    • Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • Mayo Clinic Alzheimer Disease Center, Rochester, MN, USA
    • Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA

References 

  1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383–421
  2. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002;52:168–174
  3. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005;64:1371–1377
  4. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Arch Neurol. 2004;61:668–672
  5. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology. 2007;68:1902–1908
  6. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry. 1994;151:1105–1113
  7. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21:195–218
  8. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61:76–80
  9. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, Hofman A, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55:708–716
  10. Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, et al. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 2008. 2008 Mar 29;[Epub ahead of print]
  11. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 2000;887:80–89
  12. Singh VK, Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res. 1997;31:657–660
  13. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148:S19–S26
  14. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007;92:2665–2671
  15. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: The Atherosclerosis Risk in Communities Study. Diabetes. 2004;53:2473–2478
  16. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008;28:1368–1374
  17. Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R. Mild cognitive impairment: directions for future research. Neurology. 2003;61:438–444
  18. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. 2006;367:1262–1270
  19. Eiriksdottir G, Aspelund T, Bjarnadottir K, Olafsdottir E, Gudnason V, Launer LJ, et al. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis. 2006;186:222–224
  20. Laurin D, David Curb J, Masaki KH, White LR, Launer LJ. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol Aging 2008. 2008 Mar 1;[Epub ahead of print]
  21. Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol. 2009;66:614–619
  22. Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol. 2007;27:22–31
  23. Roberts RO, Geda YE, Knopman DS, Christianson TJH, Pankratz VS, Boeve BF, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol. 2008;65:1066–1073
  24. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481–2485
  25. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008;30:58–69
  26. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  27. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, et al. Mayo's Older Americans Normative Studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97. Clin Neuropsychol. 1992;6:1–104
  28. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194
  29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed.. Washington, D.C: American Psychiatric Association; 1994;
  30. St Sauver JL, Hagen PT, Cha SS, Bagniewski SM, Mandrekar JN, Curoe AM, et al. Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc. 2005;80:203–210
  31. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233–239
  32. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545–548
  33. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci. 2008;63:50–55
  34. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttila IM, Helkala EL, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing. 2007;36:443–448
  35. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–2388
  36. Ozturk C, Ozge A, Yalin OO, Yilmaz IA, Delialioglu N, Yildiz C, et al. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline. Behav Neurol. 2007;18:207–215
  37. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB, Wilson PW, et al. Associations of adiponectin, resistin, and tumor necrosis factor-{alpha} with insulin resistance. J Clin Endocrinol Metab. 2008;93:3165–3172
  38. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000;102:1296–1301
  39. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630–635

 This study was supported by the National Institute on Aging (grants U01-AG06786, K01-AG028573, and P50-AG16574), the National Institute of Mental Health (grant K01-MH68351), and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program.

 The authors have no conflicts of interest to disclose. The sponsors had neither a role in the analysis or interpretation of these data, nor in the content of the manuscript. Appropriate approval procedures were used concerning human subjects.

PII: S1552-5260(09)00032-6

doi: 10.1016/j.jalz.2009.01.025

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 398-405 , September 2009

Article Tools